when is retatrutide going to be available FDA Approval Status: July 2026 Update Retatrutide Commercial Availability Timeline: Key

Furthermore, during the functional neuroimaging phase, it appeared that MC4R agonism possibly amplified activity in the cerebellar and supplementary motor areas while possibly deactivating the secondary somatosensory cortex, specifically when the subjects were exposed to erotic stimuli, in contrast to the placebo

If all Phase 3 trials succeed and the NDA is submitted in late 2026, FDA approval could come in late 2027 to early 2028

Murakami, M

[DOI] [PubMed] [Google Scholar] 61.Bhat J.U., Parray S.A., Aslam M., Ansari S., Nizami Q., Khanam R., Siddiqui A., Ahmad M.A

Change in the classification of certain glucosamine products